Operating Income: The income after operating expenses.
NurExone Biologic Inc. (NRXBF) had Operating Income of $-1.70M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.68M |
|
-- |
|
-- |
|
$1.70M |
|
|
Operating Income |
$-1.70M |
$0.02M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.70M |
|
$-1.66M |
|
73.61M |
|
73.61M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$1.36M |
|
$0.74M |
|
$0.78M |
|
$2.14M |
|
$0.55M |
|
-- |
|
$0.27M |
|
$0.82M |
|
$1.32M |
|
$1.32M |
|
$1.32M |
|
74.47M |
|
| Cash Flow Statement Financials | |
$-0.99M |
|
$-0.03M |
|
$0.91M |
|
$0.70M |
|
$0.59M |
|
$-0.11M |
|
$0.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-127.51% |
|
-127.51% |
|
-78.41% |
|
-127.51% |
|
$0.02 |
|
$-0.01 |
|
$-0.01 |
|